We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Quotient Clinical Receives MHRA Supplementary Accreditation

Accreditation qualifies Quotient Clinical to perform FIH studies for low molecular weight chemical entities and biologics.
News

Domainex Collaborates with St George’s University and The University of Manchester for Asthma Treatment

The £1.5 million collaboration focuses on a new drug discovery programme to provide a better treatment for asthma.
News

deCODE Discovers Sequence Variants Affecting Susceptibility to Skin Cancer

New risk factors for basal cell carcinoma that are independent of fair pigmentation.
News

Leading Experts Endorse Bioheart's Muscle Stem Cell MyoCell Therapy

Bioheart announces availability of the panel discussion on myoblast therapy between distinguished physicians and scientists for playback.
News

Microscopic Beads Could Help Create Designer Immune Cells that Ignore Transplanted Organs

The future of organ transplantation could include microscopic beads that create "designer" immune cells to help patients tolerate their new organ, MCG researchers say.
News

deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis

Findings offer target for drugs to better regulate calcium metabolism, and are integrated into deCODEme™.
News

Domainex and Ark Therapeutics Extend Drug Discovery Agreement

Domainex continues providing Ark with hit-finding and lead optimization services for drug discovery against exciting therapeutic targets.
News

Vantia Therapeutics’ Lead Candidate VA106483 Demonstrates Positive Anti-Diuretic Effect in Phase IIa Trial in Nocturia

The trial showed VA106483’s success in producing a predictable sustained anti-diuretic effect in patients.
News

DuoCort: New Chronotherapy for Adrenal Insufficiency

DuoCort publishes data from its Phase I study for the rare and life threatening disease adrenal insufficiency.
News

Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab® Systems

New funding will enable Gyros to drive the further commercialization of its Gyrolab technology.
Advertisement